VERONA PHARMA PLC - ADR (VRNA) 10.22 +0.79 (+8.38%)
10.22 +0.79 (+8.38%)
US9250501064 - ADR - After market: 10.22 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 26.52. This target is 159.49% above the current price.
VRNA was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VRNA.
In the previous month the buy percentage consensus was at a similar level.
VRNA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-29 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-26 | Piper Sandler | Initiate | Overweight |
| 2022-06-17 | Wedbush | Maintains | Outperform |
| 2021-11-12 | Canaccord Genuity | Maintains | Buy |
| 2021-09-13 | HC Wainwright & Co. | Initiate | Buy |
| 2021-05-03 | Canaccord Genuity | Maintains | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA